Enjoy complimentary customisation on priority with our Enterprise License!
The Global Cardiovascular and Soft Tissue Repair Patches Market size is estimated to grow by USD 1.82 billion at a CAGR of 7.95% between 2022 and 2027.
Myocardial infarction (MI), along with other cardiovascular problems, is becoming prevalent in the majority of the population. This increasing prevalence of coronary artery disease, obesity, diabetes, hypertension, a sedentary lifestyle, smoking, and reduced physical activities are expected to fuel the risk factors for cardiovascular diseases such as MI. According to the CDC, in the US, about half (47%) of Americans have at least one of these factors, and each year, about 790,000 Americans have a heart attack. Furthermore, the rapid increase in the geriatric population is also fuelling the incidence of MI. Hence, such factors are expected to drive the requirement for cardiovascular and soft tissue repair patches, which, in turn, will positively impact market growth.
To learn more about this report, Request Free Sample
This report provides a detailed analysis of the market by Application (Soft tissue repair, Cardiac repair, Vascular repair, Pericardial repair, and Dural repair ), Raw Material (ePTFE, Biomaterial, and tissue-engineered material ), and Geography (North America, Europe, Asia, and Rest of World (ROW)).
The soft tissue repair segment is estimated to witness significant growth during the forecast period. There is a rise in demand for the soft tissue repair segment due to the increasing prevalence of cardiovascular disorders over the past decade. Hypercholesterolemia is a risk factor for cardiovascular diseases that increases the chances of acquiring cardiovascular diseases of atherosclerotic origin. Atherosclerosis is a severe medical condition that impacts the arteries that supply blood to the heart.
Get a glance at the market contribution of various segments View a PDF Sample
The soft tissue repair segment was the largest segment and was valued at USD 1.23 billion in 2017. Atherosclerosis is one of the main causes of use of coronary artery disease and is described as a plaque inside the artery or vessel wall. The main component of plaque is cholesterol which increases the risk of developing atherosclerosis. Hypercholesterolemia is the main cause of developing atherosclerosis and it has no symptoms. As a result, the majority of people are unaware of the condition. Hence, due to the increasing prevalence of hypercholesterolemia. It is expected to drive the growth of this segment which in turn will drive the global market during the forecast period.
ePTFE mainly stands for expanded polytetrafluoroethylene. This segment is widely used in the manufacture of different medical accessories such as wound-care materials, medical device enclosures, vent caps, IV administration sets, spike vents, surgical smoke filters, and suction filters. The main benefit of ePTFE is that it offers a more consistent and repeatable biomimetic environment for in vivo-like cell phenotypes. Furthermore, several vascular and cardiac surgeries, such as cardiovascular and soft tissue repair patches, use surgical sutures produced by ePTFE. Hence, such benefits are expected to drive the growth of the segment, which in turn will drive the market growth during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. One of the main factors driving the market in North America is the factors such as the increasing incidence of MI and the availability of reimbursement schemes. Some of the key factors leading to the increasing prevalence of MI include obesity, diabetes, high blood pressure, smoking, hereditary, stress, and illicit drugs. Furthermore, the use of drugs among the US population is also significantly contributing to the market growth in the region. Additionally, several factors, such as the rising geriatric population in the US and increasing support from the government for people to have treatments at affordable prices, are expected to drive the market growth in the region during the forecast period.
The Cardiovascular and Soft Tissue Repair Patches Market is witnessing growth, driven by rising cases of congenital heart diseases and hernias. According to the Centers for Disease Control and Prevention, conditions like Atrial Septal Defect and ventricular septal defect affect millions worldwide, with prevalence rates ranging from 1 to 4%. Innovations in tissue engineering materials and regenerative cardiac repair patches, developed by institutions like Tel Aviv University and companies like Teijin Limited, are addressing these challenges. Despite concerns such as sedentary lifestyles, the market is evolving, with advancements leading to product approvals and expanding application niches, offering new opportunities for category market growth and informed market decisions.
The market growth is propelled by the escalating incidence of MI. Factors such as coronary artery disease, obesity, diabetes, hypertension, sedentary lifestyle, smoking, and reduced physical activities are amplifying the risk of cardiovascular diseases, notably MI. According to the Centers for Disease Control and Prevention (CDC), nearly half of Americans possess at least one of these risk factors, with approximately 790,000 Americans suffering from a heart attack annually.
Moreover, the burgeoning geriatric demographic significantly contributes to market expansion. Aging correlates with a decline in vital physiological components and antioxidants, leading to cellular, tissue, and molecular damage. Consequently, the prevalence of diseases rises. These trends are anticipated to propel market growth, offering diverse application niches, obtaining product approvals, and facilitating informed market decisions.
Advances in diagnostic modalities are a major trend in the market. The main two components which are used for diagnosing heart diseases such as MI include the pathological component and the clinical component. The pathological component highly depends on evidence indicating myocardial cell death, whereas the clinical component relies on electrocardiographic, biochemical, and imaging modalities for diagnosing MI.
There is a significant improvement in the diagnostic methods for heart disorders such as MI due to several advancements in technology. As a result, it helps in better assessments of physiological and biochemical alterations. Furthermore, imaging modalities have also helped in the early diagnosis of MI and related cardiovascular problems. Hence, such benefits are expected to drive the global cardiovascular and soft tissue repair patch market growth during the forecast period.
The lack of skilled cardiac surgeons is a major challenge restraining market growth. There has been a rapid change in surgical training over time, and are significantly challenged by ethical and legal concerns for patient safety. There is a shortage of skilled highly skilled surgeons, physicians, and technicians in both developing and developed countries which is leading to a demand-supply gap.
One of the key reasons for this demand-supply cap is due to an increase in the number of experienced healthcare professionals who are nearing retirement. The scarcity of qualified laboratory personnel and surgeons will increase the complications and risks during surgeries. For instance, there is a significant shortage of cardiac surgeons in developing economies like India. Hence, such factors are expected to hinder the global cardiovascular and soft tissue repair patch market growth during the forecast period.
Buy Now Full Report and Discover More
The market growth analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The Market forecasting report also includes detailed analyses of the competitive landscape of the market and information about 15 market Companies, including:
B.Braun SE: The company offers cardiovascular soft tissue repair patches called DurAVR TAVR system, which is in the clinical trial phase of development.
Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.
The market is witnessing significant growth, driven by the rising prevalence of cardiovascular diseases and soft tissue defects such as congenital heart diseases and hernias. According to the Centers for Disease Control and Prevention (CDC), conditions like Atrial Septal Defect and ventricular septal defect affect millions worldwide. Hernias, including inguinal, ventral, and congenital diaphragmatic hernias, contribute to the burden, with a prevalence rate of 1 in 4%.
The market is witnessing significant growth, driven by the increasing incidence rate of various hernias such as inguinal hernias, ventral hernias, umbilical hernias, and abdominal wall hernias. According to the University of California San Francisco Department of Surgery and Osaka Medical College, millions of hernia repair surgical procedures are performed annually. The market is segmented into the soft tissue segment and the cardiac repair segment, with the Eptfe segment also playing a crucial role, as highlighted by NCBI.
Despite potential in regions and contributions from key players, challenges such as junk food intake, alcohol and cigarettes, customers' lack of awareness, high costs of treatments, and the presence of alternative treatments persist. Complications such as adhesion, seroma, recurrence, allergic reactions, and hematomas also impact the market. However, the cardiovascular and soft tissue repair patches market report points to recent developments, trade regulations, import-export analysis, production analysis, and value chain optimization as critical factors. Additionally, the impact of domestic and localized market players, along with opportunities in emerging revenue pockets and changes in market regulations, underscores the dynamic nature of this market.
The market growth and forecasting report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Cardiovascular and Soft Tissue Repair Patches Market Scope |
|
Market Report Coverage |
Details |
Page number |
155 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.95% |
Market growth 2023-2027 |
USD 1.82 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
6.73 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Anteris Technologies Ltd., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Braile Biomedica, CorMatrix Inc., Edwards Lifesciences Corp., Glycar SA, Integra Lifesciences Corp., Labcor Laboratorios Ltda., LeMaitre Vascular Inc., Shockwave Medical Inc., Tisgenx Inc., Vascudyne Inc., W. L. Gore and Associates Inc., Aegis Lifesciences Pvt. Ltd., and Maverick Biosciences Pty Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Raw Material
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.